Helpline 07939 046 030
Freephone 0300 102 17 22*

Sian & Connor’s story

03 February 2022

Hi, my name is Sian and my fiancé is Connor. We want to share our story with others and help raise awareness of NF2.

Our baby boy Reuben was born sleeping (stillborn) on 14th December 2021. Our pregnancy wasn’t the easiest, we faced numerous problems but despite all we continued to fight on for our little soldier. We were 24 weeks pregnant with Reuben when he was born, he weighed 1lb 4oz and was so perfect in every way.

We first discovered problems in our pregnancy at 16 weeks, both of Reuben’s kidneys were moderately dilated, we were under two weekly monitoring with our consultant. We were obviously worried but didn’t think anything of it really. We then discovered he had a cleft lip and palate at our 20-week scan. Each time we were scanned we were told more bad news, we cried for days, worrying about all the operations our little boy would face so soon after birth. But again, we decided to fight on and protect our son as much as we possibly could.

Our consultant advised us to have an amniocentesis. Although we were terrified of the 1 in 100 risk of miscarriage, we decided to go ahead with testing and prayed for the best. If only we knew what was to come.

Ten long days later, we had our microarray results back. I remember the initial phone call with the hospital, asking us to go in at 9am the next day. I could hear the worry in the midwives’ voice, I burst out crying and rang Connor. Heartbreakingly, we found out Reuben had 2 rare genetic disorders, NF2 and MN1. Both we had never heard of. A video appointment with our local genetics’ consultant was arranged and from here we discovered the severity of Reuben’s development. NF2 currently has no cure and affects approximately 1 in 35,000 children and adults globally. It causes tumours to grow throughout the nervous system, mainly affecting his brain, spine, organs and limbs. MN1 is a disorder which causes learning disabilities and Reuben also risked being deaf and blind due to the NF2, these are just a few of the horrific problems he faced. It felt as if our world was falling apart. Our perfect longed-for baby boy was not the healthy baby I thought I was carrying.

We were transferred over to another local hospital, for more specialised medical input. Our 23-week scan showed that Reuben’s kidneys were now severe, and it wasn’t just his kidneys which were filled with fluid, his ureters were also now dilated. Our problems were progressing. I had contacted my community midwife the week before as I felt reduced movements, but I was told everything was ok. I started to feel paranoid, like I was going crazy, worrying.

But unfortunately, at 24 weeks we lost our precious boy. We didn’t get the opportunity to spend any time with our son alive, his heart had stopped beating well before birth. This made things even more unbearable. The hopes and dreams we had of our life with him had all come crashing down on us. We have two other children; Laila (13) and Harper (5). They were absolutely heartbroken to discover their little brother was not coming home. The guilty feeling ate us alive, we felt as if we had caused our son to be so poorly. This was the hardest part for me as a mother who is supposed to protect my unborn baby, I felt as if I had failed him.

It has now been 7 weeks since we lost our little boy, people tell us time is a healer, and I do hope as time goes on life becomes a little more bearable. But for now, we are trying to process why everything went so wrong and adapt to a life without our son.

Connor and I were offered genetic testing, we are awaiting results to see if NF2 and MN1 was something we passed on, or whether it was that Reuben was just very unlucky and it happened at conception. Regardless of our results, we would love to help and support others in a similar situation to us and raise awareness of NF2. As I previously stated, NF2 is something we had never came across or heard of before.

We would love to give back to two amazing charities which really helped us along the way.

The Honeysuckle team at Liverpool Women’s Hospital allowed us to create beautiful memories with our son, which is the only thing we have left now. We created his foot and handprints and they organised a blessing for Reuben. They allowed us to spend as much time with him as needed and provided a cold cot so that he wasn’t taken away from us. We had so many cuddles together, they dressed him for us as we were too scared of hurting him. They provided a memory box with beautiful keepsakes and gifts in, which we keep in a special place in our home. They contacted a funeral director and made the initial arrangements for us – something no parents should ever have to do for their child.

The family room within the hospital was as lovely as can be. Having this place for bereaved parents to visit their sleeping angel really helped us. It meant that we could go home, freshen up and come back to the hospital to spend as much time with our son as we needed. The room was calm and relaxing, so you felt quite at home. There was only one room in the hospital, so only one family at a time could visit their sleeping angel – we were lucky and were never turned away.

Nerve Tumours UK also supported us massively, a charity we had never heard of before. When we first knew about Reuben’s diagnosis, I remember feeling so isolated and lonely. I asked family if they had ever heard of it, none of them had. I began putting “NF2 support groups” into google to find as much support as I could. I found a group on Facebook and somebody pointed out Nerve Tumours UK. I joined this group straight away and reached out for advice of ways we could make Reuben’s life more pain free.

"Nerve Tumours UK provided us with so much support very quickly and put us in contact with a leading specialist NF2 nurse and genetic consultant in NF2 who spent many hours on the phone and video consultations. We feel that nothing was too much trouble. We can’t even begin to explain how much this really helped us."

The hours spent sat crying reading other people’s NF2 stories but knowing there was support at the end of the phone and speaking to people with the same condition as our unborn son was very comforting. At present there is no cure for this terrible disease, so support from this charity is crucial for those living with this condition.

We would love to give something back to both these incredible charities by raising money for whatever they need. Whether this be more cold cots for sleeping babies, upgraded equipment or to help provide another room for families to cherish the last moments together with their child. Whether it be Nerve Tumours UK hosting patient days, being able to answer many more phone calls to patients and families affected by NF2 or helping to find a CURE. We really appreciate every little thing that was done for us during our heart-breaking time. We simply can’t thank them enough.

Now that I am 7 weeks post-partum, we will be walking at least 24 miles per week whatever the weather – 24 miles as Reuben was born at 24 weeks gestation. What better way to raise money for an amazing cause and combat our mental health! We will be doing this each week until Reuben’s due date 2nd April 2022.

So that’s 216 miles we will be walking in honour of our beautiful son. Any donations would be very much appreciated via the GofundMe link. Let’s support many more bereaved families and those affected with NF2.

Thank you for taking the time to read our story.

Reuben’s mummy and daddy

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK